Press Releases

 
Press Releases
Date Title and Summary View
Apr 27, 2009 CAMBRIDGE, Mass., April 27, 2009 – Zafgen, Inc., a private venture-backed biopharmaceutical company focused on developing novel obesity therapeutics, today announced that Thomas Hughes, Ph.D., president and chief executive officer and Maria Rupnick, M.D., Zafgen co-founder, cardiologist at Brigham and Women’s Hospital and instruct...
Mar 25, 2009 Cambridge, MA, March 25, 2009 – Zafgen, Inc., a private venture-backed biopharmaceutical company focused on developing novel obesity therapeutics, today announced that Dr. Thomas Hughes, Ph.D., president and chief executive officer, will present a company overview at several upcoming conferences. ...
Jan 29, 2009 Harlow, UK and Cambridge, MA, January 29, 2009 – Argenta Discovery Ltd., the contract research and Respiratory R & D company, and Zafgen, Inc., a private venture-backed biopharmaceutical company focused on developing novel obesity therapeutics, today announced that they have entered into a major drug discovery collaboration. Under ...
Oct 16, 2008 CAMBRIDGE, Mass., October 16, 2008 – Zafgen Inc., a private venture-backed biopharmaceutical company focused on developing novel obesity therapeutics today announced that Thomas Hughes, Ph.D. will present at the 2008 Boston Biotech R&D Conference, at 8:20 a.m. (EST) on October 22, 2008 at Harvard Medical School. This conference will...
Sep 9, 2008 CAMBRIDGE, Mass., September 9, 2008 – Zafgen Inc., a private venture-backed biopharmaceutical company focused on developing novel obesity therapeutics today announced that Thomas Hughes, Ph.D., has been named the company’s first chief executive officer. Dr. Hughes was formerly vice president and global head, cardiovascular and...
Page: FirstPrevious ...
11
= add release to Briefcase